Osteosarcoma: Review of the Past, Impact on the Future. The American Experience-Reference-Cited by-同舟云学术

Osteosarcoma: Review of the Past, Impact on the Future. The American Experience

Published:2009 Issue: Volume: Page:239-262
ISSN:0927-3042
Container-title:Cancer Treatment and Research
language:
Short-container-title:

Author:

Jaffe Norman

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4419-0284-9_12.pdf

Reference117 articles.

1. Jaffe N, Traggis D, Enriquez C. Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-16210) and vincristine (NSC-6757) in the treatment of osteogenic sarcoma. Cancer Chemother Rep. 1971;55:181-191.

2. Sullivan MP, Sutow WW, Taylor G. l-phenylalanine mustard as treatment for metastatic osteogenic sarcoma in children. J Pediatr. 1963;63:227-237.

3. Sutow WW, Sullivan MP, Fernbach DJ, et al. Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. Cancer. 1975;36:1598-1602.

4. Wilbur JR, Sutow WW, Sullivan MP, et al. Successful treatment of rhabdomyosarcoma with combination chemotherapy and radiation therapy. Proc ASCO. 1971;7:56.

5. Sutow WW, Sullivan MP, Wilbur JR, et al. The study of adjuvant chemotherapy in osteogenic sarcoma. J Clin Pharmacol. 1975;15:530-533.

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The management of osteosarcoma in children and adolescents in a resource-limited setting: quality improvement considerations to improve treatment outcomes;BMC Cancer;2024-08-28

2. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1;Biology Direct;2024-06-07

3. MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway;Cell Death Discovery;2024-04-25

4. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway;Experimental Cell Research;2024-03

5. Revision surgery for periprosthetic fracture of distal femur after endoprosthetic replacement of knee joint following resection of osteosarcoma;Frontiers in Oncology;2024-02-12